Mark D. Reeth, General Counsel&VP Corporate Compliance at SALIX PHARMACEUTICALS LTD (SLXP), sold 1,000 shares at $48.91 ($49K) on 2012-05-01, disclosed to the SEC on 2012-05-03.
Scheduled sale ($49k) by General Counsel&VP Corporate Compliance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SLXP | SELL | 2010-06-15 | $155K | — | Filing → |
| SLXP | SELL | 2010-05-19 | $126K | — | Filing → |
| SLXP | SELL | 2009-11-24 | $80K | — | Filing → |